Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALA: Nebulized Ropivacaine for Pediatric Laparoscopic Appendectomy
NCT02624089Phase 2Unknown
- Sponsor
- McGill University Health Centre
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in appendicitis, sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT02624089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624089.